Trial Profile
A Phase I Study Evaluating the Proton Pump Inhibitor Pantoprazole in Combination With Doxorubicin for Advanced Cancer Patients With an Extension Cohort of Patients With Solid Tumours
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary) ; Pantoprazole (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 04 Apr 2013 Planned End Date changed from 1 Dec 2012 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 04 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Aug 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.